InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[damnthetorpedoes]

Insider trading has little-to-no bearing on NVIV's PPS. The CEO has been selling 12.5k shares per day out of his 12.5M shares but that is due to a divorce and not because he doesn't have confidence in the company. No other recent insider activity.

In actuality, there are a number of factors in the recent PPS climb. One would probebly be ONVO's uplisting to the NYSE MKT. NVIV is just about ready to follow that same path (or to the NASDAQ CM). I believe that at least some of the price and volume surge is coming from ONVO's PPS increase (from <$4 to nearly $7 in a week).

But there are other factors as well. NVIV's initial clinical trials should start by early fall and their scaffold for SCI will not require the amount of testing that pharmaceuticals typically do. And their hydrogel products will also probably be fast-tracked. They also shouldn't require capital infusion (read dilution) for at least a year, if ever. That's a huge plus.

So you have a company with more than a year's capital in the bank, with a product that may see approval by late 2014-early 2015 and others not far behind. What's not to like?